Market Stages Sharp Rebound
Indian stocks showed strong intraday recovery on April 2, 2026, erasing significant early losses to end higher. The Sensex dropped to an intraday low of 71,546 before recovering to close at 73,320, a gain of about 2.5%. The Nifty 50 similarly fell to 22,183 and finished at 22,713. This rebound was driven by value buying and short-covering as prices fell. A stronger rupee, its biggest daily jump in over 12 years possibly due to Reserve Bank of India action, also boosted investor confidence. The market's ability to rally over 2,000 points from its low indicated solid domestic investor support, even amid global unrest.
Geopolitical Fears and Economic Headwinds
The market's gains came despite concerning global news. U.S. President Donald Trump's strong warnings about potential strikes on Iran over the next few weeks ended hopes for quick de-escalation, pushing Brent crude prices up sharply to $109.41 and briefly $111.02 per barrel. This oil price jump, alongside mixed domestic economic data, created a complex outlook. India's manufacturing growth slowed to its lowest point in nearly four years in March 2026, with the HSBC India Manufacturing PMI dropping to 53.9, the weakest since June 2022. Rising costs, tough competition, and market uncertainty from global conflicts contributed to this slowdown. Additionally, government hikes in jet fuel and commercial LPG prices fueled inflation worries. These issues underscore the delicate state of India's economic recovery and raise the risk of higher imported inflation, which could hurt company profits and consumer spending.
Sector Split and Investor Movements
Sector performance varied widely. The IT sector stood out as a strong performer, with the Nifty IT index jumping 2.6%. HCLTech, Tech Mahindra, Infosys, and TCS were key drivers of this gain. HDFC Securities pointed out that the IT index's recent 24% drop over three months has made its valuations appealing, trading around 17.8 times forward earnings, about 16% below its 10-year average. The Nifty IT index is currently valued at 20.6 times earnings, down from its 3-year average of 29.2 times. In contrast, the Nifty Pharma index fell nearly 1% following reports that the U.S. government might impose tariffs on drug companies that don't lower prices at home. Although generics are likely exempt, the uncertainty surrounding potential trade measures worried investors. Foreign portfolio investors (FPIs) continued selling, withdrawing about ₹10,000 crore on April 2, 2026. March 2026 saw record FPI outflows of ₹1.17 lakh crore, the highest in any calendar month. This is the second year in a row with significant FPI selling. However, domestic mutual funds (MFs) were major buyers, investing nearly ₹90,000 crore in March. ICICI Securities estimates MFs put about ₹80,000 crore into equities during March's market slump to counter foreign investor selling. This strong domestic funding is crucial for market support against foreign investor wariness.
Underlying Risks Remain
However, the market's strength might hide serious weaknesses. A six-week losing streak for the Sensex and Nifty before this rebound suggests a strong bearish mood. FPIs sold Indian stocks worth ₹1.8 lakh crore in FY26, a record annual outflow, indicating a drop in global confidence due to geopolitical stress, a weaker rupee, and worries about India's economic outlook. The rise in oil prices, nearing $110 per barrel, risks widening India's current account deficit, boosting inflation, and shrinking company profits, especially since many Indian firms import crude. The manufacturing slowdown to its weakest pace in nearly four years, alongside rising costs, creates a tough environment for industrial production. Additionally, potential U.S. tariffs on branded drugs, even if exempting generics, create major uncertainty over policy for the pharmaceutical sector, a key export area. Jefferies noted Sun Pharma is most affected, though its innovative products are made outside the U.S., potentially facing a 15% tariff. While markets often recover from geopolitical conflicts, the current combination of high oil prices, continued FPI selling, and a slowing domestic economy presents a more complex risk than in the past. India's market valuation premium over other emerging markets has shrunk to 27% from an average of 73%, near historical lows, but earnings forecasts are weakening due to the ongoing conflict.
Outlook Cautious
Despite the recent rebound, analysts are cautious due to ongoing geopolitical risks and economic challenges. The market's future trend will likely depend on global conflict de-escalation and stable energy prices. Motilal Oswal Financial Services notes that while valuations have eased considerably, with the Nifty trading at a 15% discount to its long-term average, India's long-term growth potential remains. However, continued FPI selling and the domestic economic slowdown suggest this recovery could face difficulties, particularly if oil prices stay high or geopolitical tensions worsen. The upcoming fiscal year (FY27) is eyed for a potential recovery from the challenging events of FY26.